Synthetic peptide within Human POLR2G aa 145-153 (C terminal) conjugated to Keyhole Limpet Haemocyanin (KLH). The exact sequence is proprietary.Database link: P62487
Conjugate
Unconjugated
Applications
Application Notes
WB: 1/100 - 1/500; Flow Cyt: 1/10 - 1/50.
Target
Alternative Names
POLR2G; polymerase (RNA) II (DNA directed) polypeptide G; DNA-directed RNA polymerase II subunit RPB7; hRPB19; hsRPB7; RPB7; RNA polymerase II subunit B7; RNA polymerase II 19 kDa subunit; RNA polymerase II seventh subunit; DNA-directed RNA polymerase II
DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB7 is part of a subcomplex with RPB4 that binds to a pocket formed by RPB1, RPB2 and RPB6 at the base of the clamp element. The RBP4-RPB7 subcomplex seems to lock the clamp via RPB7 in the closed conformation thus preventing double stranded DNA to enter the active site cleft. The RPB4-RPB7 subcomplex binds single-stranded DNA and RNA (By similarity). Binds RNA.
Pathway
Abortive elongation of HIV-1 transcript in the absence of Tat; DNA Repair; Disease; Dual incision reaction in TC-NER; Eukaryotic Transcription Initiation; Formation of HIV-1 elongation complex containing HIV-1 Tat; Formation of HIV-1 elongation complex in
Citations
Publication ()
Have you cited DPABH-09018 in a publication? Let us know and earn a reward for your research.
My Review for Anti-POLR2G (aa 145-153) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.